# Relates to reimbursements practices of pharmacy benefit managers

**Bill ID:** S7110
**Session:** 2023
**Sponsor:** James Skoufis
**Status:** In Senate Committee

## Summary

Ensures reimbursement practices of pharmacy benefit managers do not allow for reimbursement of an amount less than the cost of procuring the drugs.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  7110
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  May 18, 2023
  ___________
 
 Introduced  by  Sen. SKOUFIS -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health
 
 AN ACT to amend the public health  law,  in  relation  to  reimbursement
  rates of pharmacy benefit managers
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Paragraph (e) of subdivision 4  of  section  280-a  of  the
 public  health  law,  as  added  by  chapter 828 of the laws of 2021, is
 amended and a new subdivision 4-a is added to read as follows:
  (e) (I) if an appeal is denied, the  pharmacy  benefit  manager  shall
 identify the national drug code of a therapeutically equivalent drug, as
 determined  by  the federal Food and Drug Administration, that is avail-
 able for purchase by pharmacies in this state  from  wholesalers  regis-
 tered  pursuant to subdivision four of section sixty-eight hundred eight
 of the education law THAT  THE  PHARMACIST  OR  PHARMACY  PURCHASES  THE
 MAJORITY OF PRESCRIPTION DRUGS FOR RESALE FROM at a price which is equal
 to  or less than the maximum allowable cost OR OTHER REIMBURSEMENT PRIC-
 ING METHODOLOGY USED BY THE PHARMACY BENEFITS MANAGER TO DETERMINE  COST
 for that drug as determined by the pharmacy benefit manager.
  (II)  IF THE NATIONAL DRUG CODE NUMBER  PROVIDED BY THE PHARMACY BENE-
 FIT MANAGER IS NOT  AVAILABLE BELOW THE PHARMACY ACQUISITION COST  FROM
 THE  PHARMACEUTICAL  WHOLESALER  FROM  WHOM  THE  PHARMACY OR PHARMACIST
 PURCHASES THE MAJORITY OF PRESCRIPTION DRUGS FOR RESALE, THEN THE  PHAR-
 MACY  BENEFIT  MANAGER  SHALL ADJUST THE MAXIMUM ALLOWABLE COST OR OTHER
 PRICING METHODOLOGY USED BY THE PHARMACY BENEFITS MANAGER  TO  DETERMINE
 COST  ABOVE  THE  CHALLENGING  PHARMACY'S  PHARMACY ACQUISITION COST AND
 PERMIT THE PHARMACY TO REVERSE AND REBILL EACH  CLAIM  AFFECTED  BY  THE
 INABILITY  TO  PROCURE  THE DRUG AT A COST THAT IS EQUAL TO OR LESS THAN
 THE PREVIOUSLY CHALLENGED MAXIMUM ALLOWABLE COST.
  4-A. REIMBURSEMENT. (A) A PHARMACY BENEFIT MANAGER SHALL NOT REIMBURSE
 A PHARMACY OR PHARMACIST IN THIS STATE AN AMOUNT LESS  THAN  THE  AMOUNT
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD05319-02-3
 S. 7110  2
 
 THAT  THE PHARMACY BENEFIT MANAGER REIMBURSES A PHARMACY BENEFIT MANAGER
 AFFILIATE FOR PROVIDING THE SAME PHARMACIST SERVICES.
  (B)  THE AMOUNT SHALL BE CALCULATED ON A PER UNIT BASIS BASED ON THE
 SAME GENERIC PRODUCT IDENTIFIED OR GENERIC CODE NUMBER.
  ยง 2. This act shall take effect on the ninetieth day  after  it  shall
 have become a law.